United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 7 minute read Retail Industry News Walmart stock gains after Q3 FY26 beat: What’s fueling the retail giant’s momentum? Walmart stock jumped over 5% after strong Q3 results and an upgraded FY26 outlook driven by eCommerce and ad revenue growth. Find out what comes next. byVenkateshNovember 20, 2025